Global burden of thyroid cancer in 2022: Incidence and mortality estimates from GLOBOCAN
TC is a highly frequent cancer worldwide with disparities across regions, genders, and age groups. Our results provide light on the worldwide TC disease burden and facilitate regionally customized prevention measures.
Authors
- Zhangyan Lyu (ORCID: https://orcid.org/0000-0001-5833-1724)
- Yubei Huang (ORCID: https://orcid.org/0000-0003-0139-7591)
- Qiang Zhang (ORCID: https://orcid.org/0000-0002-5857-327X)
- Kexin Chen (ORCID: https://orcid.org/0000-0003-4248-7681)
- Chao Sheng (ORCID: https://orcid.org/0000-0003-2823-854X)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-7106-1578)
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1097/cm9.0000000000003284
- Citations
- 59
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 21.10
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Tianjin City
- National Key Research and Development Program of China